Development of an AAV9-mediated gene therapy for hereditary spastic paraplegia 47

被引：0
|
作者：
Scarrott, J. M. [1 ]
Coldicott, I. [1 ]
Davies, A. [2 ]
Hirst, J. [2 ]
Karyka, E. [1 ]
Bauer, C. [1 ]
Azzouz, M. [1 ]
机构：
[1] Univ Sheffield, Sheffield Inst Translat Neurosci, Sheffield, S Yorkshire, England
[2] Univ Cambridge, Cambridge Inst Med Res, Cambridge, England
来源：
HUMAN GENE THERAPY | 2019年 / 30卷 / 08期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
P03
引用
收藏
页码：A18 / A18
页数：1
相关论文
共 50 条
  • [21] Intrathecal AAV9/AP4M1 gene therapy for hereditary spastic paraplegia 50 shows safety and efficacy in preclinical studies
    Chen, Xin
    Dong, Thomas
    Hu, Yuhui
    De Pace, Raffaella
    Mattera, Rafael
    Eberhardt, Kathrin
    Ziegler, Marvin
    Pirovolakis, Terry
    Sahin, Mustafa
    Bonifacino, Juan S.
    Ebrahimi-Fakhari, Darius
    Gray, Steven J.
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2023, 133 (10):
  • [22] Correction of visual and auditory function by AAV9-mediated gene therapy in a mouse model of mucopolysaccharidosis type IIIB
    Ribera, A.
    Motas, S.
    Ramirez, L.
    Marco, S.
    Sanchez, V.
    Sanchez, X.
    Bertolin, J.
    Perez, J. A.
    Leon, X.
    Varela-Nieto, I.
    de la Villa, P.
    Haurigot, V.
    Bosch, F.
    [J]. HUMAN GENE THERAPY, 2017, 28 (12) : A67 - A67
  • [23] Correction of Visual and Auditory Function by AAV9-Mediated Gene Therapy in a Mouse Model of Mucopolysaccharidosis Type IIIB
    Ribera, Albert
    Motas, Sandra
    Ramirez, Laura
    Marco, Sara
    Sanchez, Victor
    Sanchez, Xavier
    Bertolin, Joan
    Perez, Jennifer A.
    Leon, Xavier
    Varela-Nieto, Isablel
    de la Villa, Pedro
    Haurigot, Virginia
    Bosch, Fatima
    [J]. MOLECULAR THERAPY, 2018, 26 (05) : 114 - 114
  • [24] Gene therapy approach for SPG4-based hereditary spastic paraplegia
    Piermarini, Emanuela
    Guha, Shrobona
    Altadonna, Angela J.
    Sena-Esteves, Miguel
    Qiang, Liang
    Baas, Peter W.
    [J]. JOURNAL OF NEUROCHEMISTRY, 2022, 162 : 152 - 153
  • [25] HEREDITARY PURE SPASTIC PARAPLEGIA - A STUDY OF 9 FAMILIES
    POLO, JM
    CALLEJA, J
    COMBARROS, O
    BERCIANO, J
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1993, 56 (02): : 175 - 181
  • [26] AAV9-mediated EPO gene delivery in a rat model of Parkinson's disease
    Duan, Wei-Ming
    Yang, Chun
    Xue, Yue-Qiang
    Klein, Ronald L.
    Zhao, Li-Ru
    [J]. NEUROREPORT, 2014, 25 (03) : 141 - 141
  • [27] Hereditary spastic paraplegia and the ALS2 gene
    Jansen, AC
    Meijer, I
    Gros-Louis, F
    MacGregor, DL
    Rouleau, GA
    Andermann, F
    Andermann, E
    [J]. NEUROLOGY, 2005, 64 (06) : A295 - A295
  • [28] A fourth gene in autosomal dominant hereditary spastic paraplegia
    Harbourne, G
    Byrne, PC
    Webb, S
    Hutchinson, M
    Parfrey, NA
    [J]. LABORATORY INVESTIGATION, 1996, 74 (01) : 849 - 849
  • [29] Spastin gene mutation in Japanese with hereditary spastic paraplegia
    Yabe, I.
    Sasaki, H.
    Tashiro, K.
    Matsuura, T.
    Takegami, T.
    Satoh, T.
    [J]. JOURNAL OF MEDICAL GENETICS, 2002, 39 (08) : e46
  • [30] The genetics of hereditary spastic paraplegia and implications for drug therapy
    Zuchner, Stephan
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2007, 8 (10) : 1433 - 1439
12345